Literature DB >> 24053774

Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis.

Susan Byrne1, Mark Heverin, Marwa Elamin, Cathal Walsh, Orla Hardiman.   

Abstract

An expanded hexanucleotide repeat in C9orf72 causes amyotrophic lateral sclerosis and frontotemporal dementia. All studies to date state that patients have a pathological expansion if they carry 30 or more repeats. We analysed the frequency of C9orf72 repeat expansions in a population based cohort of patients with ALS, and demonstrate that patients with between 20 and 30 repeats are phenotypically similar to patients with an expanded repeat length above 30 repeats. We propose that an intermediate repeat length may be associated with features of the C9orf72 phenotype in ALS patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24053774     DOI: 10.3109/21678421.2013.838586

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  18 in total

Review 1.  C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.

Authors:  Jennifer S Yokoyama; Daniel W Sirkis; Bruce L Miller
Journal:  Am J Neurodegener Dis       Date:  2014-03-28

2.  C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.

Authors:  Micaela Fredi; Ilaria Cavazzana; Giorgio Biasiotto; Massimiliano Filosto; Alessandro Padovani; Eugenio Monti; Angela Tincani; Franco Franceschini; Isabella Zanella
Journal:  Neuromolecular Med       Date:  2019-03-11       Impact factor: 3.843

3.  Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort.

Authors:  Jennifer Murphy; Pam Factor-Litvak; Raymond Goetz; Catherine Lomen-Hoerth; Peter L Nagy; Jonathan Hupf; Jessica Singleton; Susan Woolley; Howard Andrews; Daragh Heitzman; Richard S Bedlack; Jonathan S Katz; Richard J Barohn; Eric J Sorenson; Björn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Boguslawa A Koczon-Jaremko; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-01-22       Impact factor: 9.910

Review 4.  ALS: Recent Developments from Genetics Studies.

Authors:  Martine Therrien; Patrick A Dion; Guy A Rouleau
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

Review 5.  C9orf72 and its Relevance in Parkinsonism and Movement Disorders: A Comprehensive Review of the Literature.

Authors:  Thomas Bourinaris; Henry Houlden
Journal:  Mov Disord Clin Pract       Date:  2018-11-08

Review 6.  The epidemiology and genetics of Amyotrophic lateral sclerosis in China.

Authors:  Xiaolu Liu; Ji He; Fen-Biao Gao; Aaron D Gitler; Dongsheng Fan
Journal:  Brain Res       Date:  2018-03-01       Impact factor: 3.610

Review 7.  The Spectrum of C9orf72-mediated Neurodegeneration and Amyotrophic Lateral Sclerosis.

Authors:  Johnathan Cooper-Knock; Janine Kirby; Robin Highley; Pamela J Shaw
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

8.  Rare Variants in Neurodegeneration Associated Genes Revealed by Targeted Panel Sequencing in a German ALS Cohort.

Authors:  Stefanie Krüger; Florian Battke; Andrea Sprecher; Marita Munz; Matthis Synofzik; Ludger Schöls; Thomas Gasser; Torsten Grehl; Johannes Prudlo; Saskia Biskup
Journal:  Front Mol Neurosci       Date:  2016-10-13       Impact factor: 5.639

Review 9.  The widening spectrum of C9ORF72-related disease; genotype/phenotype correlations and potential modifiers of clinical phenotype.

Authors:  Johnathan Cooper-Knock; Pamela J Shaw; Janine Kirby
Journal:  Acta Neuropathol       Date:  2014-02-04       Impact factor: 17.088

10.  Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions.

Authors:  Johnathan Cooper-Knock; Matthew J Walsh; Adrian Higginbottom; J Robin Highley; Mark J Dickman; Dieter Edbauer; Paul G Ince; Stephen B Wharton; Stuart A Wilson; Janine Kirby; Guillaume M Hautbergue; Pamela J Shaw
Journal:  Brain       Date:  2014-05-27       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.